-
States sue to block sale of 23andMe personal genetic data without customer consent
Dozens of states are suing to block 23andMe’s sale of personal genetic data, citing concerns over customer consent and privacy violations.
-
NIH scientists publish declaration criticizing Trump's deep cuts in public health research
Scores of National Institutes of Health researchers and staffers have come forward to send their Trump-appointed leader a letter challenging policies they say undermine the NIH mission.
-
The MIND diet may help reduce Alzheimer's risk, a large study shows
Following the diet, which is heavy on leafy green vegetables and berries, is associated with a strong and consistent reduction in cognitive decline.
-
FDA grants limited approval to new Covid vaccine from Moderna
The agency approved the company’s lower-dose Covid vaccine for older adults and young people with underlying medical conditions.
-
New COVID-19 variant may be driving up cases in some parts of world, WHO says
The new variant is called NB.1.8.1. It arrives as the United States’ official stance on COVID-19 vaccination is changing.
-
Science 4 Everyone: How does allergy medicine work to relieve symptoms?
On this Science 4 Everyone, Storm Team4 Meteorologist (and science teacher!) Ryan Miller explains what happens in the body when someone has an allergic reaction and how allergy medicine works to relieve its symptoms.
-
What to know about normal pressure hydrocephalus
Normal pressure hydrocephalus, or NPH, is a disorder primarily impacting older adults. Here’s what you need to know.
-
Study finds more people are dying of cancer caused by alcohol
While the overall rate of cancer deaths has fallen, a new study found that more people are dying of cancer caused by alcohol.
-
How shoddy science is fueling a charge to restrict abortion pill access
The FDA has been tasked with re-evaluating the safety of mifepristone after a flawed report claimed it has a high rate of serious complications.
-
The US hasn't seen a human bird flu case in 3 months. Experts are wondering why
Health officials are urging vigilance as reports of bird flu cases in humans appear to have stopped. Experts are wondering why.
-
Biotechnology company Regeneron buying 23andMe for $256 million
Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million. The genetic testing company had filed for bankruptcy protection.
-
FDA approves Novavax COVID-19 shot but with unusual restrictions
The FDA has issued a long-awaited approval of Novavax’s COVID-19 vaccine but with unusual restrictions.
-
Trump administration halts research to help babies with heart defects
James Antaki has worked for over 30 years on a device to help infants with holes in their hearts and other defects. Now it’s all at risk.
-
Cancer before age 50 is increasing. A new study looks at which types
A new U.S. government study provides the most complete picture yet of early-onset cancers, defined as cancer diagnosed before age 50.
-
What is Opvee?
Opvee is a nasal spray that reverses overdoses from fentanyl and other opioids that received FDA approval in 2023.
-
Man voluntarily bitten by snakes hundreds of times could help make a better treatment
Around 110,000 people die from snakebite every year, according to the World Health Organization. Making antivenom is expensive and difficult.
-
Red and itchy eyes may be due to overpopulation of eyelash mites
New York-based optometrist Dr. Damaris Raymondi says an overpopulation of eyelash mites, which is a condition called demodex blepharitis, can cause eye discomfort.
-
Wegovy treated a serious form of liver disease in a major clinical trial
The Phase 3 clinical trial found that Wegovy reduced inflammation and scarring in people with metabolic dysfunction-associated steatohepatitis, or MASH.
-
What is tularemia?
Tularemia, commonly known as “rabbit fever,” is an illness caused by bacterial infection that can be spread by insect bites and handling infected animals, according to the CDC.
-
Can ecotourism fill the void with drastic cuts to science funding?
As the Trump administration continues slashing budgets of groups like the National Science Foundation, scientists may increasingly need to rely on private tour companies for their research. In contrast, global research shows 74% of Americans want our leaders to do more to address climate change. Meteorologist Chase Cain traveled to Antarctica to explore how ecotourism could help persuade climate skeptics...